Analysis of the viability shows similar results to those previously observed in 2D culture including a significant increase of anti-tumor effects after dual targeting of miR-21 and KRAS compared to TPN-KRAS alone and combo-NT (Figure 3D). This evidence concerns the gene KRAS and neoplasm.